Viewing Study NCT00251459


Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2026-04-11 @ 2:45 AM
Study NCT ID: NCT00251459
Status: COMPLETED
Last Update Posted: 2014-03-10
First Post: 2005-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Sponsor: Genentech, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Choroidal Neovascularization View
None Age-related Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SAILOR View
None CNV View
None AMD View
None CNV secondary to AMD View